Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald I Shulman

Showing results (11-20 of 418) with videos related to

Pageof 42
Sort By:
Science (New York, N.Y.)|January 22, 2005
Mitochondrial dysfunction and type 2 diabetesBradford B Lowell, Gerald I Shulman
Obesity (Silver Spring, Md.)|April 29, 2006
New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopyKitt Falk Petersen, Gerald I Shulman
Hepatology (Baltimore, Md.)|August 10, 2013
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetesAndreas L Birkenfeld, Gerald I Shulman
Aging|December 6, 2013
Treating fatty liver and insulin resistanceRachel J Perry, Gerald I Shulman
Trends in Cancer|February 17, 2020
Mechanistic Links between Obesity, Insulin, and CancerRachel J Perry, Gerald I Shulman
Cell Metabolism|September 5, 2017
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic DiseasesVarman T Samuel, Gerald I Shulman
The Journal of Biological Chemistry|August 16, 2020
Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risksRachel J Perry, Gerald I Shulman
The New England Journal of Medicine|November 7, 2019
Nonalcoholic Fatty Liver Disease, Insulin Resistance, and CeramidesVarman T Samuel, Gerald I Shulman
Trends in Pharmacological Sciences|May 29, 2017
Roles of Diacylglycerols and Ceramides in Hepatic Insulin ResistanceMax C Petersen, Gerald I Shulman
Cell Metabolism|May 8, 2012
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistanceFrançois R Jornayvaz, Gerald I Shulman
Pageof 42

Showing results (11-20 of 418) with videos related to

Sort By:
Pageof 42
Science (New York, N.Y.)|January 22, 2005
Mitochondrial dysfunction and type 2 diabetesBradford B Lowell, Gerald I Shulman
Obesity (Silver Spring, Md.)|April 29, 2006
New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopyKitt Falk Petersen, Gerald I Shulman
Hepatology (Baltimore, Md.)|August 10, 2013
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetesAndreas L Birkenfeld, Gerald I Shulman
Aging|December 6, 2013
Treating fatty liver and insulin resistanceRachel J Perry, Gerald I Shulman
Trends in Cancer|February 17, 2020
Mechanistic Links between Obesity, Insulin, and CancerRachel J Perry, Gerald I Shulman
Cell Metabolism|September 5, 2017
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic DiseasesVarman T Samuel, Gerald I Shulman
The Journal of Biological Chemistry|August 16, 2020
Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risksRachel J Perry, Gerald I Shulman
The New England Journal of Medicine|November 7, 2019
Nonalcoholic Fatty Liver Disease, Insulin Resistance, and CeramidesVarman T Samuel, Gerald I Shulman
Trends in Pharmacological Sciences|May 29, 2017
Roles of Diacylglycerols and Ceramides in Hepatic Insulin ResistanceMax C Petersen, Gerald I Shulman
Cell Metabolism|May 8, 2012
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistanceFrançois R Jornayvaz, Gerald I Shulman
Pageof 42